Selected Grants
TRPM8 in eye health and disease
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2029Inhibiting Rev1-mediated DNA translesion synthesis for cancer therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2028Identifying essential molecular mechanisms for advanced prostate cancer growth by a new chemical compound
ResearchCollaborator · Awarded by Department of Defense · 2024 - 2027DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2026TRPM8 in eye health and disease
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2029Inhibiting Rev1-mediated DNA translesion synthesis for cancer therapy
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2028Identifying essential molecular mechanisms for advanced prostate cancer growth by a new chemical compound
ResearchCollaborator · Awarded by Department of Defense · 2024 - 2027DART.3-Revolutionizing Neuropsychiatric Treatment through Noninvasive, Programmable Cell-Type-Specific Neuropharmacology
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2027Developing equilibrative nucleoside transporter inhibitors as non-opioid pain therapeutics
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2024 - 2026Neuroactive steroids as novel psychiatric treatments: mechanistic studies
ResearchCo Investigator · Awarded by Washington University in St. Louis · 2021 - 2026Pharmacological Sciences Training Grant
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2020 - 2025Interrogating the cholinergic basis of opioid reinforcement with subcellular precision
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025Development of MESH1 inhibitors to treat ferroptosis-associated neurodegeneration
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2024Structural and chemical biology of human equilibrative nucleoside transporters
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2020 - 2024Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2023Testing D5 compounds in a human version of a published ELISA system
ResearchCo Investigator · Awarded by D5 Therapeutics, Inc · 2021 - 2022Structural Biological Development of Fungal-Specific Calcineurin Inhibitors
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2014 - 2022Structure guided design of novel adenosine reuptake inhibitors
FellowshipCollaborating Investigator · Awarded by American Heart Association · 2020 - 2021Structural and Mechanistic Characterization of MraY Catalysis and Inhibition
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2020Pharmacological Sciences Training Program
Inst. Training Prgm or CMEParticipating Faculty Member · Awarded by National Institutes of Health · 1975 - 2020GAANN - Department of Chemistry
Inst. Training Prgm or CMEMentor · Awarded by Department of Education · 2015 - 2019Thermo Lumos Tribrid High-Resolution Accurate-Mass Tandem Mass Spectrometer
EquipmentMajor User · Awarded by National Institutes of Health · 2018 - 2019Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens
ResearchCo Investigator · Awarded by National Institutes of Health · 2018 - 2019Study of Subglutinol A as a Potential Immunomodulatory Agent
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2016 - 2018Human Stringent Response as Novel Therapeutic Approaches for Breast Cancers
ResearchCo Investigator · Awarded by Department of Defense · 2015 - 2018MRI: Acquisition of a Triple Quadrupole LC/MS System
EquipmentMajor User · Awarded by National Science Foundation · 2015 - 2018Targeting Rev1-mediated Translesion Synthesis for Cancer Therapy
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2015 - 2017PKC zeta-Specific Inhibitors for Treatment of Methamphetamine Addiction
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2009 - 2011Purchase of a Q-TOF LC/MS System
EquipmentMajor User · Awarded by National Institutes of Health · 2010 - 2011External Relationships
- D5 Therapeutics
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.